Related Experiment Video
Updated: May 7, 2026

Proteomics to Identify Proteins Interacting with P2X2 Ligand-Gated Cation Channels
Published on: May 18, 2009
Pannexin channels: the emerging therapeutic targets
Misbahuddin Mohammad, Hamed Said Habib1
1Rabigh College of Medicine (Liason office), Health Colleges Library, Building No. 13, King Abdulaziz University PO Box 80200, Jeddah 21589, Saudi Arabia. drmisbah98@gmail.com.
Abstract:
Intercellular communication plays a pivotal role in various physiological functions. This is mainly done through gap junctions and trans-membrane channels. The structural proteins forming these channels are different in vertebrates and invertebrates namely connexins and innexins respectively. Recently, a new class of proteins playing a crucial role in intercellular communication was discovered and named pannexins. They are found to have similar homology to innexins. Earlier they were also thought to form gap junctions and hemi channels on oppositional cell surfaces like connexins but later they were found to have different structure, location and function than connexins. Their main role is in the initiation and propagation of cellular calcium waves and ATP release. They are also considered an integral part of the greater purinergic and adrenergic receptor complexes. They are implicated in wide variety of biochemical and pathophysiological functions ranging from apoptosis, inflammation, ischemia, seizures and immune response; to paracrine signaling, vasodymanics, tumor genesis, cellular differentiation and development. Due to their ubiquitous distribution and involvement in myriad cellular functions, they are considered as potential therapeutic targets for diseases like hypertension, epilepsy and immune disorders.
Related Concept Videos
Non-gated Ion Channels
Compared to the gated ion channels, the non-gated channels, also known as leakage or passive channels, have no gating mechanism.
Pharmacogenomics: Identification of New Drug Targets
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Targets for Drug Action: Overview
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Fusion of Secretory Vesicles with the Plasma Membrane
In 1993, Jim Rothman proposed that the antiparallel pairing of vesicular and transmembrane SNAREs, or...
